M
Masatoshi Ishigami
Researcher at Nagoya University
Publications - 297
Citations - 4686
Masatoshi Ishigami is an academic researcher from Nagoya University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 245 publications receiving 3440 citations.
Papers
More filters
Journal ArticleDOI
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Rod S Taylor,Rebecca J. Taylor,Susan Bayliss,Hannes Hagström,Patrik Nasr,Jörn M. Schattenberg,Masatoshi Ishigami,Hidenori Toyoda,Vincent Wai-Sun Wong,Noam Peleg,Amir Shlomai,Giada Sebastiani,Yuya Seko,Neeraj Bhala,Zobair M. Younossi,Quentin M. Anstee,Quentin M. Anstee,Stuart McPherson,Stuart McPherson,Philip N. Newsome,Philip N. Newsome +20 more
TL;DR: Biopsy-confirmed fibrosis is found to be associated with risk of mortality and liver-related morbidity in patients with NAFLD, with and without adjustment for confounding factors and in Patients with reported NASH.
Journal ArticleDOI
Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
Eizaburo Ohno,Yoshiki Hirooka,Akihiro Itoh,Masatoshi Ishigami,Yoshiaki Katano,Naoki Ohmiya,Yasumasa Niwa,Hidemi Goto +7 more
TL;DR: New morphologic criteria were useful to identify the malignant potentials of IPMNs to identify predictors of malignancy using contrast-enhanced endoscopic ultrasound (CE-EUS).
Journal ArticleDOI
Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Teiji Kuzuya,Yoshiaki Katano,Takashi Kumada,Hidenori Toyoda,Isao Nakano,Yoshiki Hirooka,Akihiro Itoh,Masatoshi Ishigami,Kazuhiko Hayashi,Takashi Honda,Hidemi Goto +10 more
TL;DR: Whether antiviral therapy with lamivudine is beneficial in patients after initial treatment for hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) is investigated.
Journal ArticleDOI
Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors
Takuya Ishikawa,Akihiro Itoh,Hiroki Kawashima,Eizaburo Ohno,Hiroshi Matsubara,Yuya Itoh,Yosuke Nakamura,Masanao Nakamura,Ryoji Miyahara,Kazuhiko Hayashi,Masatoshi Ishigami,Yoshiaki Katano,Naoki Ohmiya,Hidemi Goto,Yoshiki Hirooka +14 more
TL;DR: EUS has higher sensitivity in preoperative localization of PETs compared with MDCT and US, and the characteristics of EUS and CE-EUS findings in malignant PETs were clarified, and they will improve the diagnostic accuracy ofPETs.
Journal ArticleDOI
A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.
Yoshiki Hirooka,Akihiro Itoh,Hiroki Kawashima,Kazuo Hara,Koji Nonogaki,Toshifumi Kasugai,Eizaburo Ohno,Takuya Ishikawa,Hiroshi Matsubara,Masatoshi Ishigami,Yoshiaki Katano,Naoki Ohmiya,Yasumasa Niwa,Koji Yamamoto,Toru Kaneko,Mie Nieda,Kiyoshi Yokokawa,Hidemi Goto +17 more
TL;DR: It has been shown that DC-based vaccination combined with GEM administration induces tumor antigen-specific CTLs in the patient with partial remission, and this combined therapy was considered to be synergistically effective and may have a role in the therapy of pancreatic cancer.